Krishnan Suma 4
4 · Krystal Biotech, Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Krystal Biotech (KRYS) 10% Owner Suma Krishnan Sells 25,000 Shares
What Happened Suma Krishnan, a reported 10% owner of Krystal Biotech (KRYS), sold a total of 25,000 shares in open-market transactions on March 4, 2026, generating approximately $6.58 million in proceeds. The sales were executed in multiple trades at prices ranging from about $256.68 up to $266.93 depending on the lot; the filing lists weighted-average prices for each block (individual block prices: $257.32, $258.54, $259.61, $260.37, $261.41, $262.35, $263.58, $264.64, $265.16, $266.42).
Key Details
- Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (timely — within the typical 2-business-day requirement).
- Total shares sold: 25,000; approximate total proceeds: $6,580,269.
- Sale blocks and reported proceeds (examples): 6,000 sh @ $265.16 ≈ $1.59M; 4,852 sh @ $264.64 ≈ $1.28M; 3,667 sh @ $260.37 ≈ $954,762; smaller blocks range ~407–3,667 shares.
- Transaction code: S = Sale.
- Sales were made pursuant to a Rule 10b5-1 trading plan adopted Sept 4, 2025; plan effective Dec 4, 2025 and terminates Dec 4, 2026 (or earlier upon completion).
- Several footnotes state prices reflect weighted averages of multiple trades and provide the trade ranges; fuller breakdowns are available on request to the SEC/issuer/security holders.
- Shares owned after the transactions are not specified in this Form 4; certain related holdings (spouse and Krishnan Family Trust) are reported separately and disclaimed here except to the extent of pecuniary interest.
Context
- These were sales under a pre-arranged 10b5-1 plan, which is commonly used to execute trades at predetermined times and is viewed as routine rather than a direct signal of changed insider sentiment.
- As a 10% owner (not necessarily an executive), Krishnan is a significant shareholder; related holdings and transactions by her spouse and family trust are reported on separate filings.
Insider Transaction Report
Form 4
Krishnan Suma
DirectorPresident, R&D10% Owner
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-04$257.32/sh−407$104,729→ 1,427,748 total - Sale
Common Stock
[F4]2026-03-04$258.54/sh−589$152,280→ 1,427,159 total - Sale
Common Stock
[F5]2026-03-04$259.61/sh−668$173,419→ 1,426,491 total - Sale
Common Stock
[F6]2026-03-04$260.37/sh−3,667$954,762→ 1,422,824 total - Sale
Common Stock
[F7]2026-03-04$261.41/sh−2,931$766,198→ 1,419,893 total - Sale
Common Stock
[F8]2026-03-04$262.35/sh−1,938$508,430→ 1,417,955 total - Sale
Common Stock
[F9]2026-03-04$263.58/sh−2,248$592,535→ 1,415,707 total - Sale
Common Stock
[F10]2026-03-04$264.64/sh−4,852$1,284,019→ 1,410,855 total - Sale
Common Stock
[F11]2026-03-04$265.16/sh−6,000$1,590,979→ 1,404,855 total - Sale
Common Stock
[F12]2026-03-04$266.42/sh−1,700$452,918→ 1,403,155 total
Holdings
- 90,000(indirect: By Trust)
Common Stock
- 50,000(indirect: By Trust)
Common Stock
[F13]
Footnotes (13)
- [F1]The Reporting Person may be deemed to beneficially own shares of the Issuer's common stock directly owned by the Reporting Person's spouse, Krish S. Krishnan. Such shares and transactions by the Reporting Person's spouse are not included in this Form 4, as they are being reported separately on a Form 4 filed by her spouse. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein.
- [F10]The transaction was executed in multiple trades ranging from $264 to $264.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F11]The transaction was executed in multiple trades ranging from $265 to $265.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F12]The transaction was executed in multiple trades ranging from $266 to $266.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F13]Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and her spouse are each joint beneficial owners of the trust with joint voting and investment control, and holdings and transactions by the Krishnan Family Trust are also reflected on the separate Form 4 filed by her spouse.
- [F2]The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025. The Rule 10b5-1 trading plan started on December 4, 2025 and will terminate on December 4, 2026, or earlier in accordance with the terms of the Rule 10b5-1 trading plan, including upon completion of the sale of all of the shares of the Company's common stock subject to the Rule 10b5-1 trading plan.
- [F3]The transaction was executed in multiple trades ranging from $256.68 to $257.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The transaction was executed in multiple trades ranging from $257.93 to $258.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F5]The transaction was executed in multiple trades ranging from $258.98 to $259.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F6]The transaction was executed in multiple trades ranging from $259.98 to $260.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F7]The transaction was executed in multiple trades ranging from $261 to $261.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F8]The transaction was executed in multiple trades ranging from $262 to $262.8. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F9]The transaction was executed in multiple trades ranging from $263 to $263.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Signature
/s/ Suma M. Krishnan|2026-03-06